Scientists have found that even before symptoms appear, these metabolic weaknesses can set the stage for conditions such as depression, bipolar disorder, and schizophrenia. The findings open the door to treatments that repair cellular function rather than simply adjusting neurotransmitters, marking a potential turning point in the prevention and management of psychiatric disorders worldwide.

A Global Vision for Psychiatric Discovery
In a recent Genomic Press interview featured in Genomic Psychiatry, Dr. Bruce M. Cohen discusses groundbreaking discoveries that are transforming how psychiatry understands and treats complex brain disorders. As the Robertson-Steele Professor of Psychiatry at Harvard Medical School and Director of the Program for Neuropsychiatric Research at McLean Hospital, Dr. Cohen reflects on nearly fifty years of research and places his work within a growing body of evidence that is redefining approaches to mental health care worldwide.

Mitochondrial Mysteries Transform Treatment Paradigms
The interview details how Dr. Cohen’s team has identified fundamental disruptions in cellular energy metabolism that appear to underlie major psychiatric conditions. These discoveries offer major promise for developing targeted treatments that could be applied across diverse populations. His studies demonstrate that brain cells derived from people with schizophrenia, bipolar disorder, and Alzheimer’s disease show intrinsic metabolic dysfunctions that may be corrected before illness symptoms develop.

This metabolic perspective represents a fundamental shift from the neurotransmitter-based theories that have dominated psychiatry for decades. Dr. Cohen emphasizes that the brain depends more than any other organ on precise energy generation and cell-to-cell communication. His findings suggest that stabilizing these essential processes could help prevent or reduce psychiatric symptoms in at-risk individuals around the world.

Dr. Cohen’s multidisciplinary research strategy integrates genomics, brain imaging, and cellular modeling to create a comprehensive view of mental illness. This unified framework is giving scientists new tools to better understand the biology of mood, psychotic, and cognitive disorders that affect people across cultures and continents.